Access cutting-edge major depressive disorder treatment through this clinical trial at a research site in Marietta. Study-provided care at no cost to qualified participants.
Access major depressive disorder specialists in Marietta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related major depressive disorder treatment provided free
This is a randomized, parallel-group, double-blind, placebo-controlled, monotherapy study to evaluate the efficacy, safety, and tolerability of SPT-300 (GlyphAllo) in adults with major depressive disorder (MDD), with or without anxious distress.
Sponsor: Seaport Therapeutics
Check if you qualify for this major depressive disorder clinical trial in Marietta, GA
If you're searching for major depressive disorder treatment options in Marietta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Marietta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced major depressive disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.